Fasenra Prices, Coupons, Copay Cards & Patient Assistance
Fasenra (benralizumab) is a member of the interleukin inhibitors drug class and is commonly used for Asthma, and Eosinophilic Granulomatosis with Polyangiitis.
The cost for Fasenra (30 mg/mL) subcutaneous solution is around $5,197 for a supply of 1 milliliter(s), depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Fasenra prices
Subcutaneous Solution
30 mg/mL
Fasenra subcutaneous solution
from $5,197.33
for 1 milliliter(s)
Quantity | Per unit | Price |
---|---|---|
1 milliliter | $5,197.33 | $5,197.33 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Fasenra Coupons, Copay Cards and Rebates
Fasenra offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Fasenra Access 360 Co-pay Savings Program
Eligible commercially insured patients pay $0 per injection with savings of up to $13,000 per year.
- Applies to:
- Fasenra
- Number of uses:
- per prescription per year
Form more information phone: 844-275-2360 or Visit website
Patient Assistance & Copay Programs for Fasenra
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: AZ&Me Prescription Savings Program for people without insurance
Eligibility requirements:- Must have no prescription coverage for needed medication
- Varies
- Not required
- The patient must also be a US resident.
- People who are in Medicare and may be eligible for the Limited Income Subsidy can apply. However, if they are accepted into the LIS, they are no longer eligible for the AZ& Me Prescription Savings Program. Eligibility determined on a case-by-case basis.
- Fasenra (benralizumab) Injection; Subcutaneous
- Fasenra Pen (benralizumab) Injection; Subcutaneous
More information please phone: 800-292-6363 Visit Website
Provider: AZ&Me Prescription Savings Program for people with Medicare Part D
Eligibility requirements:- Contact program for details.
- Varies
- Not required
- The patient must also be a US resident.
- Eligibility determined on a case-by-case basis. *Patient must participate in Medicare Part B, Medicare Part D or Medicare Advantage This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
- Fasenra (benralizumab) Injection; Subcutaneous
- Fasenra Pen (benralizumab) Injection; Subcutaneous
More information please phone: 800-292-6363 Visit Website
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Fasenra (benralizumab) Injection; Subcutaneous
- Fasenra Pen (benralizumab) Injection; Subcutaneous
More information please phone: 866-316-7263 Visit Website
Provider: Fasenra 360 Self-Injection Support
Eligibility requirements:- Not specified
- Not Required
- Not specified
- Must be residing in the US or US territory
- Education and support services are available; Contact program for details
- Fasenra (benralizumab) Disposal Container
More information please phone: 833-360-4357 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
More about Fasenra (benralizumab)
- Fasenra consumer information
- Check interactions
- Compare alternatives
- Reviews (76)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding